New evidence supports continuous infusion for GI cancers

New research just published online by JNCCN-; Journal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic gastrointestinal (GI) cancers, such as FOLFOX, FOLFIRI, or FOLFIRINOX, it is possible to administer 5-FU solely through continuous infusion, minus the bolus (quick-delivery via intravenous push) component, without negatively affecting patient outcomes.

Just five minutes of activity a day could reduce blood pressure

Modest daily exercise, as little as five minutes, is linked to lower blood pressure, with significant benefits from longer activity durations.

November 11, 2024

Novo Nordisk will join legal row over FDA’s removal of semaglutide from shortage list

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

March 6, 2025

New bipartisan House bill includes major PBM reforms

A bipartisan House bill introduced Friday afternoon would add all sorts of new transparency measures around healthcare and serve up major PBM reforms as members

September 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.